ArticleJACC. CardioOncology2022

Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer.

Adam S Potter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.